XTX Topco’s GlucoTrack GCTK Stock Holding History

XTX Topco’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-231	Closed	-$2.41K	–	2642
2025 Q1	$2.41K	Buy	231 +160	+225%	+$10.7K	﹤0.01%	2320
2024 Q4	$31.9K	Buy	+71	New	+$90.2K	﹤0.01%	1971

Other funds holding GCTK

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's GCTK Position: Q2 2025 in Review

XTX Topco sold out of GlucoTrack (GCTK) in Q2 2025, closing a stake of 231 shares — an estimated $2.41K sold.

XTX Topco first reported a position in GCTK in Q4 2024 and held it in 2 quarters. The position peaked at $31.9K in Q4 2024. 10 funds tracked by Wall St. Rank hold GCTK as of Q2 2025.

XTX Topco reported no remaining GlucoTrack position as of Q2 2025 after selling out during the quarter.
XTX Topco sold 231 GlucoTrack shares in Q2 2025, an estimated $2.41K.
XTX Topco first reported a position in GlucoTrack in Q4 2024 and held it in 2 quarters.
XTX Topco's GlucoTrack position peaked at $31.9K in Q4 2024.
10 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.